Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer [Phase 2]
Phase 2 trial evaluating chemotherapy and peripheral blood stem cell transplant followed by Aldesleukin and Sargramostim in inflammatory Sta…
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: A Global Study to Compare the Effects of Fulvestrant and Arimidex in a Subset of Patients With Breast Cancer. [Phase 3]
Phase 3 trial comparing fulvestrant and anastrozole in hormone receptor-positive breast cancer. Results were posted in May 2017.
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: Standard Genetic Counseling With or Without a Decision Guide in Improving Communication Between Mothers Undergoing BRCA1/2 Testing and Their Minor-Age Children [Phase 3]
A Phase 3 trial evaluated whether adding a decision guide to standard genetic counseling improves communication between mothers undergoing B…
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: Biomarkers in Tissue Samples From Patients With Breast Cancer Treated With Bevacizumab
An update on biomarker analyses from tissue samples of breast cancer patients treated with bevacizumab, aiming to identify markers associate…
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: Identifying Genes That Predict Recurrence in Women With Breast Cancer Treated With Chemotherapy
This completed trial update reports on identifying gene biomarkers that predict recurrence in women with breast cancer treated with chemothe…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: Studying Tumor Samples From Women Who Have Undergone Chemotherapy for Breast Cancer
This clinical trial studies tumor samples from women who have undergone chemotherapy for breast cancer; the study status is completed.
-
CLINICAL_TRIALS research · 2017-05-17Clinical Trial Update: Biomarkers in Tissue Samples From Patients With Ductal Breast Carcinoma in Situ
Clinical trial update reporting on biomarkers analyzed in tissue samples from patients with ductal carcinoma in situ (a non-invasive form of…
-
CLINICAL_TRIALS trial_result · 2017-05-16Clinical Trial Update: Mammosite Breast Brachytherapy Optimization in the Treatment of Breast Carcinoma [NA]
Update on a trial evaluating Mammosite breast brachytherapy optimization for breast cancer; the study is completed and results were posted.
-
CLINICAL_TRIALS trial_result · 2017-05-16Clinical Trial Update: Female Sexual Dysfunction in Breast Cancer Patients
A clinical trial update investigating female sexual dysfunction in patients with breast cancer. The current status of the trial is unknown.
-
CLINICAL_TRIALS trial_result · 2017-05-16Clinical Trial Update: Trial of Tomotherapy in Breast Cancer [NA]
This clinical trial update describes a study evaluating tomotherapy for breast cancer. The current trial status is unknown and no phase is s…
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: A Dose-escalation Vaccine Trial in HER2-overexpressing Patients With High-risk Breast Cancer [Phase 1]
An update on a Phase 1 dose-escalation vaccine trial in HER2-overexpressing high-risk breast cancer patients. GlaxoSmithKline is sponsoring …
-
CLINICAL_TRIALS trial_result · 2017-05-12Clinical Trial Update: Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer [Phase 3]
Phase 3 trial evaluating the efficacy and safety of Kisqali (LEE011) in postmenopausal women with advanced/metastatic breast cancer has comp…
-
FDA label_change · 2017-05-12FDA Approved: FARESTON — Supplemental Application (Kyowa Kirin, Inc.)
FDA supplemental approval for Fareston (toremifene citrate) to update the labeling for this breast cancer therapy.
-
CLINICAL_TRIALS trial_result · 2017-05-12Clinical Trial Update: Acellular Dermal Matrix in Tissue Expander Breast Reconstruction: A Prospective, Randomized, Clinical Trial Comparing SurgiMend PRS and AlloDerm RTU [Phase 4]
A Phase 4 clinical trial compares two acellular dermal matrices, SurgiMend PRS and AlloDerm RTU, for tissue expander breast reconstruction i…
-
CLINICAL_TRIALS research · 2017-05-12Clinical Trial Update: Stereotactic Body Radiation Therapy Combined With Anti-PD-1 Antibody in Metastatic Triple Negative Breast Cancer [Phase 1]
Phase 1 study evaluating stereotactic body radiation therapy combined with an anti-PD-1 antibody in metastatic triple-negative breast cancer…
-
CLINICAL_TRIALS trial_result · 2017-05-10Clinical Trial Update: Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancer [Phase 2]
Phase 2 trial evaluating a neoadjuvant regimen of sunitinib, paclitaxel, doxorubicin, and cyclophosphamide in stage IIB-IIIC breast cancer; …
-
CLINICAL_TRIALS research · 2017-05-10Clinical Trial Update: Docetaxel 2-weeks Regimen in the Treatment of HER2 Negative Metastatic Breast Cancer [Phase 2]
This clinical trial update describes a Phase 2 study evaluating a 2-week Docetaxel regimen for HER2-negative metastatic breast cancer. The s…
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Women With Locally Recurrent or Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating a cancer vaccine, trastuzumab, and vinorelbine in women with locally recurrent or metastatic breast cancer; the stu…
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Temozolomide in Subjects With Brain Metastases of Either Malignant Melanoma, Breast, or Non-small Cell Lung Cancer (P02064) [Phase 2]
Phase 2 study evaluating temozolomide for brain metastases from melanoma, breast cancer, or non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: ZoNantax - Zolendronic Acid as Neoadjuvant Therapy Plus Anthracycline and Taxane in Locally Advanced Breast Cancer [Phase 2]
A completed Phase 2 trial evaluating ZoNantax (zoledronic acid) as neoadjuvant therapy combined with anthracycline and taxane in locally adv…
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Patients With Locally Recurrent or Metastatic Breast Cancer [Phase 2]
Phase 2 study evaluating vaccine therapy, trastuzumab, and vinorelbine in locally recurrent or metastatic breast cancer has completed with r…
-
CLINICAL_TRIALS research · 2017-05-09Clinical Trial Update: Blood Samples From Patients on a Clinical Trial to CINV During HSCT
This is an update on a clinical trial involving collection of blood samples from patients undergoing chemotherapy-induced nausea and vomitin…
-
CLINICAL_TRIALS withdrawal · 2017-05-09Clinical Trial Update: AUY922 With Lapatinib and Letrozole for ER+ HER2+ Advanced Breast Cancer [Phase 1, Phase 2]
A Phase 1/2 trial of AUY922 in combination with lapatinib and letrozole for ER-positive, HER2-positive advanced breast cancer has been withd…
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant [Phase 3]
A Phase 3 trial of moxifloxacin to prevent bacterial infections in patients who have undergone a donor stem cell transplant was terminated.
-
CLINICAL_TRIALS withdrawal · 2017-05-09Clinical Trial Update: Dietary Energy Restriction and Omega-3 Fatty Acids on Mammary Tissue [EARLY_Phase 1]
A Phase 1 study evaluating dietary energy restriction and omega-3 fatty acids on mammary tissue in breast cancer patients has been withdrawn…